Today: 9 April 2026
DroneShield (ASX:DRO) share price dives nearly 10% — what investors watch before Friday’s trade
29 January 2026
2 mins read

DroneShield (ASX:DRO) share price dives nearly 10% — what investors watch before Friday’s trade

SYDNEY, Jan 29, 2026, 17:17 (AEDT) — Market closed.

  • DroneShield dropped 9.9% to A$3.56, slipping for the third session in a row.
  • This move comes after the company’s December-quarter update and a 4Q25 investor call held earlier this week.
  • Attention shifts to February’s audited FY2025 results and if the selling pressure eases.

DroneShield Ltd shares fell 9.9% on Thursday, closing at A$3.56 after dipping to A$3.53 earlier in the session. The stock has now dropped roughly 15% over the past three trading days. Volume was around 21.5 million shares, per Investing.com data. Investing.com Australia

This decline is significant since DroneShield stands out as one of the ASX’s most closely followed defence tech stocks, attracting heavy retail interest and known for swift reactions to contract and cash-flow news.

Thursday’s drop raises a straightforward question for traders heading into the next session: is this just a reset after a strong run, or the beginning of another downward stretch as expectations get scaled back?

DroneShield reported a 94% jump in revenue from customers to A$51.3 million for the December quarter, according to its update this week. Customer cash receipts surged 142% to A$63.5 million. The company’s SaaS segment, subscription software sold as a service, grew to A$4.6 million, and operating cash flow flipped positive at A$7.7 million. DroneShield also flagged that its FY2025 and FY2026 figures remain unaudited management estimates, pending the audited results due in February.

Looking ahead to calendar 2025, the company reported customer revenue hitting A$216.5 million, up sharply from A$57.5 million in 2024. Cash receipts stood at A$201.6 million, with SaaS revenue contributing A$11.6 million. The January sales pipeline was pegged at A$2.09 billion, alongside “secured” revenue for 2026 of A$95.6 million. The company cautioned, however, that pipeline numbers are unweighted for probability and not guaranteed. Company Announcements

DroneShield hosted an investor call at 9 a.m. Sydney time on Wednesday, led by CEO Oleg Vornik, CFO Carla Balanco, and Chief Product Officer Angus Bean, the company confirmed in an ASX notice. Company Announcements

During the call, Vornik highlighted the carry-over into 2026, saying the company had “essentially $100 million” locked in cash receipts and revenue. He also mentioned that profit numbers are expected to be released alongside the annual results in roughly a month. Investing.com

The stock has held onto a volatility premium since late 2025. In response to executive share sales in mid-November that triggered a sharp drop, DroneShield rolled out a mandatory minimum shareholding rule for its directors and senior management, Reuters reported in December. Reuters

The downside is clear-cut: defence procurement tends to be uneven, with deliveries and payments often shifting between quarters. The company has also warned that some crucial numbers remain unaudited until the annual report is released.

Heading into Friday, traders will be eyeing if the stock can hold its ground after finishing close to the day’s lows, while watching for any new contract news that might shift sentiment.

February’s audited FY2025 results and annual report are the next key catalyst. Investors will scrutinize margins, cash conversion, and how quickly DroneShield is shifting toward a bigger software and subscription footprint.

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Woodside share price rises as WDS flags softer 2026 output, oil jumps on Iran fears
Previous Story

Woodside share price rises as WDS flags softer 2026 output, oil jumps on Iran fears

South32 share price hits 52-week high as copper sets records — what investors watch next
Next Story

South32 share price hits 52-week high as copper sets records — what investors watch next

Go toTop